LIMN
NASDAQ
US
Liminatus Pharma, Inc. - Class A Common Stock
$0.18
▲ +$0.00
(+2.34%)
Vol 494K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$16.5M
Beta
0.36
52W
$1–$34
Price Chart
Similar Stocks
CELZ
Creative Medical Technology Holdings Inc
$5.1M
PMCB
PharmaCyte Biotech Inc
$7.3M
SYBX
Synlogic Inc
$13.1M
TCRT
Alaunos Therapeutics Inc
$7.2M
XBIO
Xenetic Biosciences Inc
$5.0M
CDIO
Cardio Diagnostics Holdings Inc
$4.9M
BRTX
BioRestorative Therapies Inc
$10.4M
ERNA
Ernexa Therapeutics Inc
$9.4M
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | — | — | — | — | — |
| Current Ratio | 0.17 | — | 0.09 | 0.09 | 0.09 | 0.42 |
Key Ratios
ROA (TTM)
-95.3%
EPS (TTM)
$-0.20
52W High
$33.66
52W Low
$0.61
$0.61
52-Week Range
$33.66
How does LIMN compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
LIMN valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
LIMN profitability vs Biotechnology peers
ROE
—
▼
0%
below
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-95.3%
▼
104%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
LIMN financial health vs Biotechnology peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.4
▼
91%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.4
▼
63%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
LIMN fundamentals radar
LIMN
Peer median
Industry
LIMN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
LIMN vs peers: key metrics
Latest News
No related news yet